Abstract:Abstract Objective The objective of this study is to validate C-Reactive Protein (CRP) measurement in Non-Human Primate (NHP) serum using the ADVIA 1800 analyzer. Methods CRP was validated in NHP serum using the ADVIA 1800 analyzer. Validation testing included intra-assay precision, inter-assay precision, accuracy, linearity of dilution, limit of quantitation (LOQ), limit of detection (LOD), reference interval, carry-over, correlation, and stability. Samples were collected into tubes containing no anti-coagulant. Intra-assay precision was determined by analyzing two biological samples and the two quality control levels of Bio-Rad Lyphochek Immunology Plus Control 10 consecutive times (in duplicate) within a single run. Inter-assay precision was determined by analyzing two biological samples and the two quality control levels of Bio-Rad Lyphochek Immunology Plus Control six times for six days over a 10-day period. Accuracy was calculated using the data obtained from the inter-assay precision testing. For linearity of dilution, calibrator material and diluted specimen samples were analyzed in duplicate. The LOQ was determined by diluting the low-level calibrator material to produce a value at the low end of the reportable range. Diluted material was tested six times within the same run. The LOD was determined by assaying the appropriate blank 10 times within the same run. The reference interval was determined by analyzing 21 serum samples. Correlation between the two ADVIA 1800 analyzers was determined by assaying 10 samples on both analyzers once. The carry-over of the assay was determined by analyzing the high-level quality control material followed by the low-level quality control material. Stability of serum samples was tested at room temperature, refrigerated, and frozen (at -20°C) for various durations of storage. Results Results show that measurement of CRP in NHP serum met the acceptance criteria for intra-assay precision, inter-assay precision, accuracy, linearity of dilution, limit of quantitation, carry-over, and stability. For intra-assay precision in specimen and control material, the %CV was within ±20%. The inter-assay precision for specimen and control material %CV was within ±20%. The total error observed (TEobs) was within ±20% for accuracy in control material and the obtained mean was within the acceptable range specified by the manufacturer. For linearity of dilution, the coefficient of determination was ≥0.9000 and TEobs for each dilution and calibrator level was lower than 20%. The LOQ was set at the lowest concentration for which the TEobs was within ±20%. The LOD was calculated by adding the mean concentration obtained and three times the standard deviation. The reference interval was set to the 2.5th to 97.5th percentile interval using Excel software. The carry-over was acceptable as it was ≤2%. Correlation between the two ADVIA 1800 analyzers was determined to describe any bias in result interpretation. Stability at all storage conditions was found to be acceptable with a mean %difference within ±20%. Conclusion CRP in NHP serum met the acceptance criteria for all required validation parameters. The ADVIA 1800 analyzer can be used for preclinical studies to test CRP in NHP serum.

[The use of primate tissue homogenates for quality control in the creatine kinase-MB determination with inhibiting antibodies (author's transl)]

Kinetic immunochemical method for the simultaneous quantification of creatine kinase isoenzymes

Semi-automated direct colorimetric measurement of creatine kinase isoenzyme MB activity after extraction from serum by use of a CK-MB-specific monoclonal antibody.

Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608)

High-level expression and purification of human creatine kinase MM isozymes in E.coli

The Kinetic Constants Study of Recombinant Human Muscle Creatine Kinase

Recombinant creatine kinase proteins and proposed standards for creatine kinase isoenzyme and subform assays

Primary study on stability and commutability of recombinant human muscle creatine kinase isozyme in different matrix

Capillary Isoelectric Focusing and Affinity Capillary Electrophoresis Approaches for the Determination of Binding Constants for Antibodies to the Prion Protein

Heterogeneity of Escherichia coli-expressed human muscle creatine kinase

Immunohistochemical Analyses on Serum Proteins in Nephrons of Protein-Overload Mice by "in Vivo Cryotechnique"

A-119 Performance Evaluation of a New Enzymatic Creatinine Assay on Mindray Clinical Chemistry BS-2800M Analyzer With Excellent Accuracy

Quantification of C1 inhibitor activity using a chromogenic automated assay: analytical and clinical performances

Reproducibility of measurement techniques used for creatine kinase, interleukin-6 and high-sensitivity C-reactive protein determination over a 48 h period in males and females

Preparation of Rabbit Monoclonal Antibody Against Cgmp and Development of Competitive ELISA for Cgmp

B-076 Comparison of Three Methods for the Detection of Antibodies Against Muscle-Specific Kinase

High-Performance Liquid Chromatographic Determination of Creatine Kinase Activity Influenced by Methylglyoxal

B-029 Evaluation of the Analytical Performance of Creatine Kinase, Lactate dehydrogenase L-P, Myoglobin Assays on the Atellica CI Analyzer

B-001 Method Development of C-Reactive Protein in the Serum of Non-Human Primates

A Single Residue Substitution Accounts for the Significant Difference in Thermostability Between Two Isoforms of Human Cytosolic Creatine Kinase

Quantification of tissue creatine content using capillary electrophoresis